In obese prostate cancer patients, robotic-assisted surgery to remove the prostate reduces the risk of blood loss and prolonged hospital stays, a Loyola Medicine study has found.
The study by senior author Gopal Gupta, MD and colleagues is published in the journal Current Urology. Dr. Gupta is an assistant professor in the Department of Urology of Loyola University Chicago Stritch School of Medicine.
Researchers examined records of 9,108 obese men who underwent radical prostatectomy (removal of the prostate gland and some surrounding tissue). Among all patients, 60.4 percent underwent robotic-assisted radical prostatectomy and 39.6 percent underwent open prostatectomy.
Patients undergoing robotic-assisted surgery were only 17 percent as likely to require blood transfusions and only 28 percent as likely to require prolonged hospital stays. But robotic-assisted surgery did not reduce the risk of infections and other complications, the study found.
The robotic system allows surgeons to operate through a few small incisions. Movements by the surgeon's hand or wrist are translated into highly precise movements of the surgical instruments. Every maneuver is directed by the surgeon, in real time, as the surgeon views a magnified, 3D, high-definition image of the surgical site.
Prostate cancer is the most common solid organ cancer in men in the United States. One in six men will develop prostate cancer over their lifetimes, and many will choose to have radical prostatectomies. In the past decade, the use of robotic-assisted radical prostatectomy has surpassed that of open surgery.
Obesity affects nearly 40 percent of adults in the United States. Obese patients can be challenging, because many have related conditions such as diabetes, heart disease and obstructive sleep apnea that can increase the risk of blood transfusions, complications and prolonged length of stay.
Researchers concluded the study results have these implications:
-The finding that robotic-assisted surgery reduces blood transfusion and prolonged length-of-stay even in obese patients offers a better understanding of the value of robotic surgery in challenging patients.
-For urologists, the finding that robotic and open surgery have similar complication rates implies that both techniques remain interchangeable. The surgeon's comfort level should dictate which surgical approach is used.
-For obese prostate cancer patients, the broad findings suggest that both surgical approaches are feasible and safe.
New research pinpoints key pathways in prostate cancer's vulnerability to ferroptosis